FreeStyle Libre 2 Discharge Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05822232

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05822232
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05822232. Randomized; no masking; primary purpose prevention. Start 2022-08-17 (actual); primary completion 2024-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
FreeStyle Libre 2 Discharge Trial
Condition
Diabetes Mellitus, Type 2
Condition
Hypoglycemia
Intervention (Device)
FreeStyle Libre 2 CGM
Intervention (Device)
FreeStyle Libre Pro blinded CGM
Intervention (Device)
FreeStyle Precision Neo blood glucose meter
Lead sponsor
Palo Alto Medical Foundation (class: other)
Collaborator
Abbott Diabetes Care (class: industry)
Collaborator
Emory University (class: other)

Record details

Record id
cardio:ct-nct05822232
Content hash
fb88606ef3f2a74e890cc1da6dcb7cd8c9a392c0743409dd9bd9414a1b5c0719